Fund Holdings — Finepoint Capital LP

Total Portfolio Value:
$866.88M
Total Bought:
$110.88M
Total Sold:
$56.68M
Net Transaction:
+$54.20M
Notable People:
Herbert Schwind Wagner, Fpcap Llc, Steven Laurence Lefkowitz
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
QXO, Inc.(QXO)25,750,78124,933,825-816,956$406.09M$396.45M45.73%-$9.64M
Liberty Broadband CorpCOM SER C1,994,5102,015,710+21,200$154.16M$150.69M17.38%-$3.46M
Liberty Media Corp DelCOM LBTY LIV S C0812,792+812,792$0$55.32M6.38%+$55.32M
argenx SEADR(ARGX)54,42852,928-1,500$29.50M$32.55M3.75%+$3.05M
Revolution Medicines, Inc.(RVMD)731,960710,260-21,700$33.19M$31.07M3.58%-$2.13M
Springworks Therapeutics Inc650,852748,752+97,900$20.85M$27.05M3.12%+$6.20M
Ascendis Pharma A/SADR(ASND)190,072184,872-5,200$28.38M$25.45M2.94%-$2.93M
MoonLake ImmunotherapeuticsCL A(MLTX)388,835447,935+59,100$19.61M$24.26M2.80%+$4.65M
Sarepta Therapeutics, Inc.(SRPT)133,535161,935+28,400$16.68M$19.69M2.27%+$3.01M
Lakefront Biotherapeutics NVADR(LKFT)557,762674,762+117,000$16.06M$18.56M2.14%+$2.50M
Xencor, Inc.(XNCR)0660,000+660,000$0$15.17M1.75%+$15.17M
Cytokinetics, Incorporated(CYTK)256,449318,448+61,999$13.54M$14.98M1.73%+$1.44M
Arvinas, Inc.(ARVN)574,378713,778+139,400$14.15M$13.68M1.58%-$463.8K
Avidity Biosciences Inc0391,300+391,300$0$11.38M1.31%+$11.38M
Prothena Corp PlcSHS
SHS
433,471657,071+223,600$7.25M$9.10M1.05%+$1.85M
Relay Therapeutics, Inc.(RLAY)1,626,1462,175,646+549,500$11.51M$8.96M1.03%-$2.55M
EyePoint, Inc.(EYPT)707,4041,111,104+403,700$5.65M$8.28M0.95%+$2.63M
Solid Biosciences Inc961,251961,2510$6.70M$3.85M0.44%-$2.85M
AleAnna, Inc.CL A(ANNA)027,717+27,717$0$196.8K0.02%+$196.8K
AleAnna, Inc.W EXP 12 13 202(ANNA)0490,000+490,000$0$68.6K0.01%+$68.6K
Moneyhero LimitedW EXP 09 13 202
*W EXP 09/13/202
895,000895,0000$26.9K$49.4K0.01%+$22.6K
Lakeshore Biopharma Co LtdW EXP 03 15 202489,999489,9990$24.2K$48.5K0.01%+$24.3K
Marblegate Acquisition CorpW EXP 08 31 202735,000735,0000$25.3K$25.7K0.00%+$368
Calidi Biotherapeutics Inc12,50012,5000$14.2K$14.4K0.00%+$126
Acadia Pharmaceuticals Inc905,3840-905,384$13.92M$0—-$13.92M
Calidi Biotherapeutics IncW EXP 03 14 202655,2000-655,200$8.6K$0—-$8.6K
Compass Digital Acquisition CorpW EXP 09 29 202459,9060-459,906$28.1K$0—-$28.1K
Swiftmerge Acquisition CorpW EXP 12 13 202490,0000-490,000$39.2K$0—-$39.2K
Travere Therapeutics, Inc.(TVTX)1,782,2670-1,782,267$24.93M$0—-$24.93M
Page 1 of 1
Finepoint Capital LP — 13F Holdings — Q4 2024 | TickerTrail